MEVIS MEDICAL SOLUTIONS AG (M3V.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:M3V - DE000A0LBFE4 - Common Stock
26 EUR
0 (0%)
We assign a fundamental rating of 5 out of 10 to M3V. M3V was compared to 11 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making M3V a very profitable company, without any liquidiy or solvency issues. M3V is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- M3V had positive earnings in the past year.
- In the past year M3V had a positive cash flow from operations.
- In the past 5 years M3V has always been profitable.
- Each year in the past 5 years M3V had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 17.22%, M3V belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- The Return On Equity of M3V (25.58%) is better than 100.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 14.00%, M3V belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- M3V had an Average Return On Invested Capital over the past 3 years of 17.15%. This is significantly above the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.22% | ||
| ROE | 25.58% | ||
| ROIC | 14% |
ROA(3y)19.91%
ROA(5y)19.35%
ROE(3y)32.29%
ROE(5y)30.88%
ROIC(3y)17.15%
ROIC(5y)17.35%
1.3 Margins
- M3V's Profit Margin of 26.87% is amongst the best of the industry. M3V outperforms 90.91% of its industry peers.
- In the last couple of years the Profit Margin of M3V has declined.
- The Operating Margin of M3V (23.58%) is better than 90.91% of its industry peers.
- M3V's Operating Margin has declined in the last couple of years.
- With an excellent Gross Margin value of 97.12%, M3V belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
- M3V's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.58% | ||
| PM (TTM) | 26.87% | ||
| GM | 97.12% |
OM growth 3Y-4.71%
OM growth 5Y-9.81%
PM growth 3Y-1.4%
PM growth 5Y-9.66%
GM growth 3Y-0.07%
GM growth 5Y-0.07%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so M3V is still creating some value.
- Compared to 1 year ago, M3V has about the same amount of shares outstanding.
- M3V has about the same amout of shares outstanding than it did 5 years ago.
- There is no outstanding debt for M3V. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- M3V has an Altman-Z score of 4.81. This indicates that M3V is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.81, M3V belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
- M3V has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.81 |
ROIC/WACC1.44
WACC9.73%
2.3 Liquidity
- M3V has a Current Ratio of 1.52. This is a normal value and indicates that M3V is financially healthy and should not expect problems in meeting its short term obligations.
- M3V has a Current ratio (1.52) which is in line with its industry peers.
- M3V has a Quick Ratio of 1.52. This is a normal value and indicates that M3V is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of M3V (1.52) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.52 |
3. Growth
3.1 Past
- M3V shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
- M3V shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.74% yearly.
- M3V shows a decrease in Revenue. In the last year, the revenue decreased by -2.14%.
- Measured over the past years, M3V shows a decrease in Revenue. The Revenue has been decreasing by -1.25% on average per year.
EPS 1Y (TTM)-7.41%
EPS 3Y0.13%
EPS 5Y-10.74%
EPS Q2Q%-38.82%
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y1.53%
Revenue growth 5Y-1.25%
Sales Q2Q%-7.59%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 10.40, the valuation of M3V can be described as reasonable.
- M3V's Price/Earnings ratio is rather cheap when compared to the industry. M3V is cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.30, M3V is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.4 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, M3V is valued a bit cheaper than 63.64% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, M3V is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.64 | ||
| EV/EBITDA | 9.87 |
4.3 Compensation for Growth
- The excellent profitability rating of M3V may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- M3V has a Yearly Dividend Yield of 3.83%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 2.24, M3V pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, M3V pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.83% |
5.2 History
- On average, the dividend of M3V grows each year by 24.89%, which is quite nice.
Dividend Growth(5Y)24.89%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 107.89% of the earnings are spent on dividend by M3V. This is not a sustainable payout ratio.
- The Dividend Rate of M3V has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP107.89%
EPS Next 2YN/A
EPS Next 3YN/A
MEVIS MEDICAL SOLUTIONS AG / M3V.DE FAQ
What is the ChartMill fundamental rating of MEVIS MEDICAL SOLUTIONS AG (M3V.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to M3V.DE.
What is the valuation status for M3V stock?
ChartMill assigns a valuation rating of 5 / 10 to MEVIS MEDICAL SOLUTIONS AG (M3V.DE). This can be considered as Fairly Valued.
How profitable is MEVIS MEDICAL SOLUTIONS AG (M3V.DE) stock?
MEVIS MEDICAL SOLUTIONS AG (M3V.DE) has a profitability rating of 8 / 10.
What is the financial health of MEVIS MEDICAL SOLUTIONS AG (M3V.DE) stock?
The financial health rating of MEVIS MEDICAL SOLUTIONS AG (M3V.DE) is 7 / 10.